CORVEL CORP(NASDAQ:CRVL) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 5 out of 10 to CRVL. CRVL was compared to 108 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making CRVL a very profitable company, without any liquidiy or solvency issues. CRVL has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CRVL was profitable.

In the past year CRVL had a positive cash flow from operations.

In the past 5 years CRVL has always been profitable.

In the past 5 years CRVL always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of 16.37%, CRVL belongs to the top of the industry, outperforming 97.20% of the companies in the same industry.

CRVL has a better Return On Equity (29.32%) than 95.33% of its industry peers.

CRVL has a Return On Invested Capital of 27.12%. This is amongst the best in the industry. CRVL outperforms 99.07% of its industry peers.

The Average Return On Invested Capital over the past 3 years for CRVL is significantly above the industry average of 8.14%.

		Industry Rank	Sector Rank
ROA	16.37%
ROE	29.32%
ROIC	27.12%

ROA(3y)16.54%

ROA(5y)14.38%

ROE(3y)31.63%

ROE(5y)28.18%

ROIC(3y)28.37%

ROIC(5y)24.01%

1.3 Margins

Looking at the Profit Margin, with a value of 10.12%, CRVL belongs to the top of the industry, outperforming 95.33% of the companies in the same industry.

CRVL's Profit Margin has improved in the last couple of years.

CRVL's Operating Margin of 12.64% is amongst the best of the industry. CRVL outperforms 86.92% of its industry peers.

CRVL's Operating Margin has improved in the last couple of years.

CRVL has a Gross Margin (22.40%) which is comparable to the rest of the industry.

In the last couple of years the Gross Margin of CRVL has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	12.64%
PM (TTM)	10.12%
GM	22.4%

OM growth 3Y3.75%

OM growth 5Y2.98%

PM growth 3Y4.56%

PM growth 5Y4.11%

GM growth 3Y-1.18%

GM growth 5Y0.6%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CRVL is creating value.

The number of shares outstanding for CRVL has been increased compared to 1 year ago.

CRVL has more shares outstanding than it did 5 years ago.

CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CRVL has an Altman-Z score of 19.74. This indicates that CRVL is financially healthy and has little risk of bankruptcy at the moment.

CRVL's Altman-Z score of 19.74 is amongst the best of the industry. CRVL outperforms 98.13% of its industry peers.

CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	19.74

ROIC/WACC2.99

WACC9.06%

2.3 Liquidity

A Current Ratio of 1.77 indicates that CRVL should not have too much problems paying its short term obligations.

Looking at the Current ratio, with a value of 1.77, CRVL is in the better half of the industry, outperforming 60.75% of the companies in the same industry.

A Quick Ratio of 1.77 indicates that CRVL should not have too much problems paying its short term obligations.

With a decent Quick ratio value of 1.77, CRVL is doing good in the industry, outperforming 65.42% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.77
Quick Ratio	1.77

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for CRVL have decreased by -3.31% in the last year.

The Earnings Per Share has been growing by 12.42% on average over the past years. This is quite good.

The Revenue has grown by 12.64% in the past year. This is quite good.

The Revenue has been growing slightly by 5.95% on average over the past years.

EPS 1Y (TTM)-3.31%

EPS 3Y19.94%

EPS 5Y12.42%

EPS Q2Q%-53.54%

Revenue 1Y (TTM)12.64%

Revenue growth 3Y12.9%

Revenue growth 5Y5.95%

Sales Q2Q%12.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 25.97, CRVL can be considered very expensive at the moment.

Compared to the rest of the industry, the Price/Earnings ratio of CRVL indicates a somewhat cheap valuation: CRVL is cheaper than 60.75% of the companies listed in the same industry.

When comparing the Price/Earnings ratio of CRVL to the average of the S&P500 Index (29.63), we can say CRVL is valued inline with the index average.

		Industry Rank	Sector Rank
PE	25.97
Fwd PE	N/A

4.2 Price Multiples

CRVL's Enterprise Value to EBITDA is on the same level as the industry average.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRVL is on the same level as its industry peers.

		Industry Rank	Sector Rank
P/FCF	67.57
EV/EBITDA	41.13

4.3 Compensation for Growth

CRVL has an outstanding profitability rating, which may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)2.09

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CRVL!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CORVEL CORP

NASDAQ:CRVL (2/21/2025, 8:10:59 PM)

After market: 108.54 0 (0%)

108.54

-5.73 (-5.01%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)02-04 2025-02-04/bmo

Earnings (Next)05-19 2025-05-19

Inst Owners53.92%

Inst Owner Change200.07%

Ins Owners9.67%

Ins Owner Change-0.24%

Market Cap5.57B

Analysts0

Price TargetN/A

Short Float %3.54%

Short Ratio11.48

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	25.97
Fwd PE	N/A
P/S	6.4
P/FCF	67.57
P/OCF	46.6
P/B	18.53
P/tB	21.15
EV/EBITDA	41.13

EPS(TTM)4.18

EY3.85%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)1.61

FCFY1.48%

OCF(TTM)2.33

OCFY2.15%

SpS16.96

BVpS5.86

TBVpS5.13

PEG (NY)N/A

PEG (5Y)2.09

Profitability

		Industry Rank	Sector Rank
ROA	16.37%
ROE	29.32%
ROCE	34.19%
ROIC	27.12%
ROICexc	54.9%
ROICexgc	71.73%
OM	12.64%
PM (TTM)	10.12%
GM	22.4%
FCFM	9.47%

ROA(3y)16.54%

ROA(5y)14.38%

ROE(3y)31.63%

ROE(5y)28.18%

ROIC(3y)28.37%

ROIC(5y)24.01%

ROICexc(3y)45.01%

ROICexc(5y)39.49%

ROICexgc(3y)59.7%

ROICexgc(5y)53.05%

ROCE(3y)35.76%

ROCE(5y)30.26%

ROICexcg growth 3Y1.94%

ROICexcg growth 5Y-3.26%

ROICexc growth 3Y6.17%

ROICexc growth 5Y0.54%

OM growth 3Y3.75%

OM growth 5Y2.98%

PM growth 3Y4.56%

PM growth 5Y4.11%

GM growth 3Y-1.18%

GM growth 5Y0.6%

F-Score7

Asset Turnover1.62

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	0
Cap/Depr	129.78%
Cap/Sales	4.26%
Interest Coverage	250
Cash Conversion	86.25%
Profit Quality	93.54%
Current Ratio	1.77
Quick Ratio	1.77
Altman-Z	19.74

F-Score7

WACC9.06%

ROIC/WACC2.99

Cap/Depr(3y)113.61%

Cap/Depr(5y)111.61%

Cap/Sales(3y)3.98%

Cap/Sales(5y)4.11%

Profit Quality(3y)77.48%

Profit Quality(5y)100.23%

High Growth Momentum

Growth

EPS 1Y (TTM)-3.31%

EPS 3Y19.94%

EPS 5Y12.42%

EPS Q2Q%-53.54%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)12.64%

Revenue growth 3Y12.9%

Revenue growth 5Y5.95%

Sales Q2Q%12.69%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y15.78%

EBIT growth 3Y17.13%

EBIT growth 5Y9.1%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y47.9%

FCF growth 3Y-3.19%

FCF growth 5Y2.01%

OCF growth 1Y38.6%

OCF growth 3Y1.69%

OCF growth 5Y4.76%

CORVEL CORP (CRVL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens